Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.31 |
| ▸ | POLRMT | O00411 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30165917 | 0.99 | TMPRSS2 (0.40) | TMPRSS2PIK3CDPOLRMT | |
| Bromide SCHEMBL30165903 | 0.98 | TMPRSS2 (0.40) | TMPRSS2PIK3CD | |
| Sulfuric Acid SCHEMBL30165951 | 0.96 | TMPRSS2 (0.39) | TMPRSS2 | |
| Sulfuric Acid SCHEMBL30165901 | 0.96 | TMPRSS2 (0.39) | TMPRSS2 | |
| Phosphoric Acid SCHEMBL30165932 | 0.96 | TMPRSS2 (0.40) | TMPRSS2POLRMT | |
| SCHEMBL31325796 | 0.95 | TMPRSS2 (0.40) | TMPRSS2PIK3CD | |
| Maleic Acid SCHEMBL30165883 | 0.94 | TMPRSS2 (0.38) | TMPRSS2 | |
| SCHEMBL31239302 | 0.87 | TMPRSS2 (0.39) | TMPRSS2 | |
| SCHEMBL31239307 | 0.87 | TMPRSS2 (0.39) | TMPRSS2 | |
| SCHEMBL31239301 | 0.87 | TMPRSS2 (0.39) | TMPRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117599063-B | Application of nucleoside compound in preparation of poxvirus related products | 深圳安泰维生物医药有限公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-118027040-A | Nucleoside compound for treating coronavirus infection and application thereof | 南方科技大学 | 2024-05-14 | — | — | CN | disclosed |
| CN-117964624-A | Nucleoside compound with effect of treating viral infection and application thereof | 南方科技大学 | 2024-05-03 | — | — | CN | disclosed |
| CN-117777141-A | Nucleoside compound for resisting virus infection and application thereof | 南方科技大学 | 2024-03-29 | — | — | CN | disclosed |
| CN-117599063-A | Application of nucleoside compound in preparation of poxvirus related products | 深圳安泰维生物医药有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-116370479-B | Use of compound ATV014 in the preparation of a product for the treatment of novel coronavirus infection | 南方科技大学 | 2024-02-13 | — | — | CN | disclosed |
| CN-113735862-B | Nucleoside compound for treating viral infection and application thereof | 南方科技大学 | 2024-02-02 | — | — | CN | disclosed |
| CN-116874490-A | Compound ATV014 or pharmaceutically acceptable salts thereof and pharmaceutical compositions thereof | 南方科技大学 | 2023-10-13 | — | — | CN | disclosed |
| CN-116370479-A | Use of compound ATV014 in the preparation of a product for the treatment of novel coronavirus infection | 南方科技大学 | 2023-07-04 | — | — | CN | disclosed |